Vimarsana
Biggest News Aggregation in the World

Alan Freidman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alan Freidman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alan Freidman Today - Breaking & Trending Today

TransCode Therapeutics Announces Closing of $1.2 Million Registered Direct Offering of Common ... - Vimarsana News

TransCode Therapeutics Announces Closing of $1.2 Million Registered Direct Offering of Common ...

BOSTON, Dec. 04, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that

TransCode Therapeutics Announces $1.2 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules - Vimarsana News

TransCode Therapeutics Announces $1.2 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

BOSTON, Nov. 30, 2023 -- TransCode Therapeutics, Inc. , an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has entered into a...

Nasdaq Panel Grants TransCode Therapeutics Extension for - Vimarsana News

Nasdaq Panel Grants TransCode Therapeutics Extension for

BOSTON, Oct. 27, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more...

TransCode Therapeutics Announces Pricing of $8 Million - Vimarsana News

TransCode Therapeutics Announces Pricing of $8 Million

BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more...

TransCode Therapeutics CEO Letter to Shareholders - Vimarsana News

TransCode Therapeutics CEO Letter to Shareholders

BOSTON, July 05, 2023 -- Dear TransCode Therapeutics Shareholders, I want to express the optimism that permeates the management, board, and staff of TransCode as we navigate the ever-evolving...